摘要
目的:探讨门静脉系统血栓形成的病因及介入治疗对高同型半胱氨酸血症引起门静脉血栓的疗效。方法:回顾分析河津市人民医院介入科治疗收治的1例可疑高同型半胱氨酸血症引起的门静脉系统血栓,并检索国内外相关文献。结果:高同型半胱氨酸是引起门静脉系统血栓的一个重要因素,本例可疑高同型半胱氨酸血症引起的门静脉血栓,通过经肠系膜上动脉置管间接行门静脉系统溶栓,针对病因及伴随肠梗阻症状的治疗,血栓溶解,患者恢复良好。结论:对于可疑高同型半胱氨酸血症所引起的门静脉血栓采用经肠系膜上动脉置管间接门静脉溶栓安全、有效;有明确病因的患者,针对病因的治疗也不容忽视;对于合并肠梗阻的患者,禁饮食、胃肠减压等辅助治疗同样重要。
Objective: To investigate the etiology of portal system thrombosis (PST) and the therapeutic effect of interventional therapy on PST caused by hyperhomocysteine. Methods: A case of PST caused by suspected hyperhomocysteine in Hejin People’s Hospital was retrospectively analyzed, and search the relevant literature at home and abroad. Result: Homocysteine is an important factor in PST, in this case of PST caused by suspected hyperhomocysteine, portal vein thrombolysis was performed indirectly through superior mesenteric artery catheterization, treatment for etiology and associated symptoms of intestinal obstruction, the PST dissolved and the patient recovered well. Conclusion: Indirect thrombolysis via superior mesenteric artery is safe and effective for PST caused by suspected hyperhomocysteine. For PST patient with clear pathogeny, the treatment that aims at pathogeny nots allow to ignore. For PST patients with intestinal obstruction, dietary restriction, gastrointestinal decompression and other adjuvant therapy are equally important.
出处
《临床医学进展》
2020年第1期51-55,共5页
Advances in Clinical Medicine
